p21 Waf1/Cip1 (E2R7A) Rabbit Antibody

Supplier CD BioSciences
Product # AMA-0165
Pricing 100 μL, Inquire
Product Category Antibodies
Application WB, IP
Product Usage Information Dilution Western Blotting (1:1000); Immunoprecipitation (1:50)
Reactivity Human, Mouse
Host Rabbit
Source/Isotype Rabbit IgG
MW (Target) 21 kDa
Storage Store at -20°C.
Purification Monoclonal antibody is produced by immunizing animals with recombinant protein specific to human p21 Waf1/Cip1 protein.
Background The tumor suppressor protein p21 Waf1/Cip1 acts as an inhibitor of cell cycle progression. It functions in stoichiometric relationships forming heterotrimeric complexes with cyclins and cyclin-dependent kinases. In association with CDK2 complexes, it serves to inhibit kinase activity and block progression through G1/S. However, p21 may also enhance assembly and activity in complexes of CDK4 or CDK6 and cyclin D. The carboxy-terminal region of p21 is sufficient to bind and inhibit PCNA, a subunit of DNA polymerase, and may coordinate DNA replication with cell cycle progression. Upon UV damage or during cell cycle stages when cdc2/cyclin B or CDK2/cyclin A are active, p53 is phosphorylated and upregulates p21 transcription via a p53-responsive element. Protein levels of p21 are downregulated through ubiquitination and proteasomal degradation.
Feedback